Literature DB >> 29270784

Anal canal squamous cell cancer: are surgical alternatives to chemoradiation just as effective?

Kunal Suradkar1, Emmanouil E Pappou1, Steven A Lee-Kong1, Daniel L Feingold1, Ravi P Kiran2.   

Abstract

PURPOSE: The purpose of this paper is to study long-term oncologic outcomes after different treatment strategies for anal canal cancer (SCAC).
METHODS: Patients with SCAC (2004-2013) were identified from Surveillance, Epidemiology, and End Results (SEER) database. Patients undergoing radiation (RT) were compared to those undergoing local excision (LE), abdominoperineal resection (APR), and abdominoperineal resection after radiation (RT + APR). Overall survival (OS) and cancer-specific survival (CSS) data were evaluated using Kaplan-Meier and Cox regression.
RESULTS: Two thousand seven hundred and seventy-two (83.8%) patients underwent RT, 382 (11.6%) LE, 77 (2.3%) APR, 76 (2.3%) RT + APR. Median age for the four groups was 60, 57, 64, and 56 years and 32, 49.7, 53.2, and 39.5% were male, respectively, while median tumor size was 4.4, 2.6, 5.3, and 5.5 cm, respectively. Five-year OS of RT, LE, APR, and RT + APR groups was 63.7, 79.6, 25.8, and 41.8% while CSS was 79.6, 92.5, 75.6, and 58.8%, respectively, (p < 0.001). Adjusted hazard ratios for OS for LE, APR, and RT + APR with RT as reference were 1.007 (0.702-1.444), 2.311 (1.367-3.906), and 2.072 (1.016-4.228), respectively.
CONCLUSION: These data suggest that APR does not provide better outcomes in treatment of SCAC. Chemoradiation remains the gold standard treatment for majority of patients. Local excision is associated with favorable outcomes in some circumstances.

Entities:  

Keywords:  Anal canal cancer; Nigro protocol; SEER; Squamous cell carcinoma

Mesh:

Year:  2017        PMID: 29270784     DOI: 10.1007/s00384-017-2938-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  32 in total

1.  The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies.

Authors:  Linda C Harlan; Benjamin F Hankey
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

2.  The treatment of anal carcinoma by interstitial irradiation.

Authors:  J E DALBY; R S POINTON
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1961-03

Review 3.  Anal canal and perianal epidermoid cancers.

Authors:  P R Fuchshuber; M Rodriguez-Bigas; T Weber; N J Petrelli
Journal:  J Am Coll Surg       Date:  1997-11       Impact factor: 6.113

4.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

5.  Transitional cloacogenic carcinoma of the anal canal. Clinicopathologic study of three hundred seventy-three cases.

Authors:  R G Klotz; T Pamukcoglu; D H Souilliard
Journal:  Cancer       Date:  1967-10       Impact factor: 6.860

Review 6.  Surgical management of anal cancer.

Authors:  H Gilshtein; W Khoury
Journal:  Minerva Chir       Date:  2015-02-18       Impact factor: 1.000

7.  Four decades of anal cancer in Tasmania, Australia: what do the case data tell us?

Authors:  Steve Simpson; Richard Turner
Journal:  Sex Health       Date:  2012-07       Impact factor: 2.706

8.  Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.

Authors:  B M Boman; C G Moertel; M J O'Connell; M Scott; L H Weiland; R W Beart; L L Gunderson; R J Spencer
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

9.  Understanding the burden of human papillomavirus-associated anal cancers in the US.

Authors:  Djenaba A Joseph; Jacqueline W Miller; Xiaocheng Wu; Vivien W Chen; Cyllene R Morris; Marc T Goodman; Jose M Villalon-Gomez; Melanie A Williams; Rosemary D Cress
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

10.  The epidemiology of anal cancer.

Authors:  Andrew E Grulich; I Mary Poynten; Dorothy A Machalek; Fengyi Jin; David J Templeton; Richard J Hillman
Journal:  Sex Health       Date:  2012-12       Impact factor: 2.706

View more
  2 in total

1.  Development and Validation of Prognostic Survival Nomograms for Patients with Anal Canal Cancer: A SEER-Based Study.

Authors:  Jie Tang; Liqun Zhu; Yuejiao Huang; Lixiang Yang; Dangen Ge; Zhengyu Hu; Chun Wang
Journal:  Int J Gen Med       Date:  2021-12-20

2.  High-Resolution Anoscopy Surveillance After Anal Squamous Cell Carcinoma: High-Grade Squamous Intraepithelial Lesion Detection and Treatment May Influence Local Recurrence.

Authors:  Carmelina Cappello; Tamzin Cuming; Julie Bowring; Adam N Rosenthal; Noreen Chindawi; Mayura Nathan
Journal:  Dis Colon Rectum       Date:  2020-10       Impact factor: 4.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.